Nifty
Sensex
:
:
11896.45
40558.49
-41.20 (-0.35%)
-148.82 (-0.37%)

Pharmaceuticals & Drugs

Rating :
69/99

BSE: 524774 | NSE: Not Listed

874.45
22-Oct-2020
  • Open
  • High
  • Low
  • Previous Close
  •  871.95
  •  874.45
  •  792.00
  •  832.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  252
  •  85.25
  •  874.45
  •  220.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 514.54
  • 40.64
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 539.61
  • 0.21%
  • 4.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.81%
  • 1.38%
  • 22.04%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.77%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.71
  • 9.59
  • 10.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.69
  • -0.98
  • -0.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.97
  • -1.44
  • -5.67

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 35.72

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.25
  • 0.79
  • 3.76

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.06
  • 3.30
  • 15.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
42.37
40.70
4.10%
35.44
0.00
0
37.42
34.47
8.56%
37.21
38.92
-4.39%
Expenses
28.92
32.25
-10.33%
33.14
0.00
0
34.19
27.10
26.16%
32.91
32.03
2.75%
EBITDA
13.45
8.45
59.17%
2.30
0.00
0
3.23
7.37
-56.17%
4.30
6.89
-37.59%
EBIDTM
31.74%
20.76%
6.49%
0.00%
8.64%
21.39%
11.56%
17.71%
Other Income
2.18
1.35
61.48%
0.83
0.00
0
1.19
0.73
63.01%
1.06
1.84
-42.39%
Interest
0.60
0.48
25.00%
0.60
0.00
0
0.64
0.64
0.00%
0.66
0.52
26.92%
Depreciation
2.10
1.87
12.30%
2.21
0.00
0
2.06
1.62
27.16%
1.97
1.49
32.21%
PBT
12.93
7.45
73.56%
0.32
0.00
0
1.72
5.84
-70.55%
2.74
6.72
-59.23%
Tax
3.54
2.25
57.33%
0.51
0.00
0
0.59
1.77
-66.67%
0.39
2.30
-83.04%
PAT
9.39
5.20
80.58%
-0.19
0.00
-
1.13
4.07
-72.24%
2.35
4.42
-46.83%
PATM
22.16%
12.77%
-0.53%
0.00%
3.02%
11.81%
6.30%
11.35%
EPS
15.14
8.38
80.67%
-0.30
0.00
-
1.82
6.57
-72.30%
3.78
7.13
-46.98%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
-
151.69
153.17
Net Sales Growth
-
-0.97%
 
Cost Of Goods Sold
-
64.36
62.63
Gross Profit
-
87.32
90.54
GP Margin
-
57.56%
59.11%
Total Expenditure
-
131.93
120.88
Power & Fuel Cost
-
10.30
9.02
% Of Sales
-
6.79%
5.89%
Employee Cost
-
24.04
21.16
% Of Sales
-
15.85%
13.81%
Manufacturing Exp.
-
17.22
13.21
% Of Sales
-
11.35%
8.62%
General & Admin Exp.
-
6.11
5.33
% Of Sales
-
4.03%
3.48%
Selling & Distn. Exp.
-
4.64
4.58
% Of Sales
-
3.06%
2.99%
Miscellaneous Exp.
-
5.25
4.95
% Of Sales
-
3.46%
3.23%
EBITDA
-
19.76
32.29
EBITDA Margin
-
13.03%
21.08%
Other Income
-
3.05
4.12
Interest
-
2.63
2.55
Depreciation
-
8.11
6.30
PBT
-
12.07
27.57
Tax
-
3.74
7.44
Tax Rate
-
30.99%
26.99%
PAT
-
8.34
20.13
PAT before Minority Interest
-
8.34
20.13
Minority Interest
-
0.00
0.00
PAT Margin
-
5.50%
13.14%
PAT Growth
-
-58.57%
 
EPS
-
13.45
32.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
98.96
92.12
Share Capital
3.09
3.09
Total Reserves
95.87
89.03
Non-Current Liabilities
11.62
11.90
Secured Loans
8.32
8.01
Unsecured Loans
0.00
0.00
Long Term Provisions
2.11
1.40
Current Liabilities
48.71
45.18
Trade Payables
20.83
16.12
Other Current Liabilities
6.34
5.61
Short Term Borrowings
14.60
15.31
Short Term Provisions
6.93
8.15
Total Liabilities
159.29
149.20
Net Block
67.74
60.94
Gross Block
91.81
74.07
Accumulated Depreciation
24.07
13.13
Non Current Assets
72.76
62.80
Capital Work in Progress
0.00
0.00
Non Current Investment
0.00
0.00
Long Term Loans & Adv.
5.00
1.81
Other Non Current Assets
0.01
0.04
Current Assets
86.53
86.41
Current Investments
10.65
8.69
Inventories
27.90
18.61
Sundry Debtors
26.19
33.12
Cash & Bank
3.16
3.14
Other Current Assets
18.63
7.24
Short Term Loans & Adv.
12.17
15.61
Net Current Assets
37.82
41.23
Total Assets
159.29
149.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
20.46
8.85
PBT
12.07
27.57
Adjustment
12.16
7.87
Changes in Working Capital
-0.03
-19.15
Cash after chg. in Working capital
24.20
16.29
Interest Paid
0.00
0.00
Tax Paid
-3.74
-7.44
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-20.85
-9.54
Net Fixed Assets
-7.18
Net Investments
-5.69
Others
-7.98
Cash from Financing Activity
0.00
0.00
Net Cash Inflow / Outflow
-0.39
-0.70
Opening Cash & Equivalents
0.79
1.49
Closing Cash & Equivalent
0.40
0.79

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
160.18
149.11
ROA
5.40%
13.49%
ROE
8.72%
21.85%
ROCE
11.93%
25.25%
Fixed Asset Turnover
1.83
2.07
Receivable days
71.37
78.93
Inventory Days
55.95
44.35
Payable days
47.96
48.15
Cash Conversion Cycle
79.36
75.13
Total Debt/Equity
0.29
0.29
Interest Cover
5.60
11.82

Top Investors:

News Update:


  • ICRA reaffirms NGL Fine-Chem’s long term rating at BBB+
    28th Sep 2020, 12:05 PM

    The credit rating agency has also reaffirmed the short term rating is A2

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.